What IChemE is doing to support the response
IChemE members with vast expertise in vaccine, therapeutic and diagnostic manufacturing have many vital skills required to support the response to the coronavirus.
Members from within the pharmaceutical and biochemical industries possess considerable experience in transforming early pharmaceutical development processes into commercial manufacture, including in the field of vaccines and diagnostics.
With active special interest groups focusing on pharmaceutical and biochemical manufacturing, IChemE has brought together a wealth of specialist knowledge in an area that could provide real benefit to governments at this time.
IChemE Safety Centre member companies have also collaborated to produce a paper, Managing Process Safety during the COVID-19 Pandemic, on good process safety practice.